BMP SUNSTONE (NASDAQ:BJGP)

Tuesday, November 9, 2010 | Web News
Third quarter ended September 30, 2010. Revenue increased 33.4% to $44.9 million from $33.6 million in the prior year...
Monday, August 9, 2010 | Web News
2010 Second Quarter Highlights: Revenue increased to $40.9 million from $32.5 million in the prior yea period, an increase of...
Monday, March 15, 2010 | Web News
Non-GAAP net income was $3.6 million, or $0.07 per diluted share, compared to $4.1 million, or $0.10 per...
See All Research...

At least one FIE exists in the corporate structure

BMP SUNSTONE CP, through its subsidiaries, is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China and is pursuing partnerships with other companies seeking to enter the Chinese pharmaceutical market. It is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis, clinical trial management, product registration, market research, as well as pharmaceutical marketing and distribution. BMP Sunstone's proprietary portfolio, primarily focusing on women's health and pediatrics. The Company is headquartered in Plymouth Meeting, Pennsylvania.

BMP Sunstone offers the following services in China: pre-market entry analysis; clinical trial management; product registration; market research; pharmaceutical distribution to hospitals; and pharmaceutical marketing to physicians, hospitals and other healthcare providers. (Website)

Web site: http://www.beijingmedpharm.com

Last updated March 12, 2008


Market Data powered by QuoteMedia. Terms of Use